Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.41) by 19.51 percent. This is a 32.65 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $110.000 thousand which missed the analyst consensus estimate of $190.750 thousand by 42.33 percent. This is a 87.33 percent decrease over sales of $868.000 thousand the same period last year.